The ATTC network is a UK wide group of centres addressing the unique and complex challenges of accelerating the adoption of advanced therapy medicinal products (ATMPs) into the NHS.

About the network
Our purpose
The ATTC network is dedicated to establishing robust systems for the routine delivery of ATMPs throughout the United Kingdom. Since establishment, the network has been developing and sharing a body of knowledge and practice that has facilitated the NHS to deliver advanced therapies.
What we do
The ATTC network’s current focus is on accelerating ATMP clinical trials in the UK under a £17.9m strategic initiative funded by the National Institute for Health and Care Research (NIHR) where Innovate UK provides the oversight of the funds and CGT Catapult is providing coordination of the network.
A network spread across the UK
Network activities
The network’s outputs are delivered through a series of interconnected initiatives, each addressing persistent barriers in the field:
Clinical trials acceleration
Streamlining processes and implementing innovative methodologies to expedite the procession of ATMP clinical trials.
Training and education
Developing specialised training programmes to equip researchers and healthcare professionals with the necessary skills and knowledge to navigate the complexities of ATMP trials.
Patient and public involvement and engagement
Engaging with the patient and public communities to foster understanding, awareness, and involvement in ATMP clinical trials.
Patient recruitment
Implementing strategies to improve patient access and recruitment for ATMP trials, ensuring diverse and representative participation.
Data collection and use
Enhancing data infrastructure and analytics capabilities to optimise decision-making and drive evidence-based advancements in ATMP research.
Logistics
Enhancing logistical capabilities to streamline the supply chain and ensure seamless coordination of ATMP trial activities.